Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/4879
Title: Camptothecin poly[N-(2-hydroxypropyl) methacrylamide] copolymers in antitopoisomerase-1 tumor therapy: Intratumor release and antitumor efficacy
Authors: Zamai, M.
VAN DE VEN, Martin 
Farao, M.
Gratton, E.
Ghiglieri, A.
Castelli, M.G.
Fontana, E.
d' Argy, R.
Fiorino, A.
Pesenti, E.
Suarato, A.
Caiolfa, V.R.
Issue Date: 2003
Publisher: AMER ASSOC CANCER RESEARCH
Source: Molecular cancer therapeutics, 2(1). p. 29-40
Abstract: Soluble copolymers of camptothecin (CPT), based on poly[N-(2-hydroxypropyl) methacrylamide] (pHPMA), were obtained by conjugation through the degradable spacers -Gly-Phe-Leu-Gly- or -Gly-6-aminohexanoyl-Gly-. We investigated to what extent passive accumulation and retention of hydroxypropyl methacrylamide copolymer of CPT (pHPMA-CPT) in tumors and modulation of the drug release influence efficacy. Release of CPT in vivo was detected by time-resolved phase-shift fluorescence imaging on tumor specimens, based on the evidence that free and bound drug had different fluorescence lifetimes in solution. HT-29 murine specimens, obtained at several times after treatment with 3 H-labeled free CPT, pHPMA-Gly-Phe-Leu-Gly-CPT, or pHPMA-Gly-6-aminohexanoyl-Gly-CPT, were either imaged for time-resolved phase-shift fluorescence or subjected to autoradiography. Phase shifts of CPT conjugates were equal or longer than those of free CPT, indicating the presence of both free and polymer-bound drug in the tumor, in agreement with autoradiograms. pHPMA-Gly-Phe-Leu-Gly-CPT underwent relevant intratumor hydrolysis during the first 24 h, whereas the hydrolysis of pHPMA-Gly-6-aminohexanoyl-Gly-CPT was slow. The latter showed antitumor activity at doses from 10 to 22.5 mg/kg/day against s.c. HT-29, A2780, M14, and A549 s.c. xenografts. Moreover, inhibition of tumor growth lasted for up to 73-88 days, and cures were observed on mice with orthotopic implanted HT-29; pHPMA-Gly-Phe-Leu-Gly-CPT was 2-fold more potent than pHPMAGly-6-aminohexanoyl-Gly-CPT but less tolerated. Our data suggest that the efficacy of pHPMA-CPT copolymers is related to their intratumor accumulation, and in vivo properties of releasing CPT by esterolytic and proteolytic degradation.
Keywords: SIZE-EXCLUSION CHROMATOGRAPHY; TOPOISOMERASE-I; PHASE-I; UNIVERSAL CALIBRATION; DNA CLEAVAGE; CANCER; CHEMOTHERAPY; NSC-100880; MECHANISM; DOXORUBICIN
Document URI: http://hdl.handle.net/1942/4879
ISSN: 1535-7163
e-ISSN: 1538-8514
ISI #: 000180497700004
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

WEB OF SCIENCETM
Citations

50
checked on May 14, 2022

Page view(s)

10
checked on Mar 16, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.